The A2DSRH Programme is a five-year grant provided to IGAD by the African Union Development Agency (AUDA-NEPAD). This support focuses on the Demographic Dividends and Sexual Reproductive Health Initiative for Regional Economic Communities and Member States, enhancing their capacity to build, strengthen, and scale up their national health systems and networks in providing sexual reproductive health services aligning with Goal 3 of the 2030 SDG targets to ensure healthy lives and promote well-being for all individuals of all ages across the region.
Africa Demographic Dividend, Sexual and Reproductive Health
About the Programme
Our Mandate
- To develop a Regional Sexual Reproductive Health (SRH) Strategy
- To conduct a feasibility assessment to establish the IGAD Regional Health Organisation (RHO) for strengthened regional health programming and financing.
- Encourage knowledge exchange and experience sharing among the IGAD Member States to harness regional expertise and reduce disparities in sexual and reproductive health (SRH), thereby improving general health across the region.
- To enhance capacity and deliver Technical Assistance (TA) by formulating and validating a Regional Sexual and Reproductive Health (SRH) Strategy alongside its Monitoring, Evaluation, Accountability, and Learning (MEAL) Framework. In addition, the Member States will create a regional guiding toolkit and training materials on SRH.
- To foster collaboration with other RECs by forming partnerships that implement activities focused on Health Financing and by participating in international health forums.
Focus Area
- Revitalizing and Establishing Regional SRH Coordination Governance Structures: Preparing for the validation and endorsement of the Regional SRH Strategy.
- Conducting a Feasibility Assessment: Laying the foundation for an IGAD Regional Health Organization.
- Encouraging Knowledge Exchange and Experience Sharing: Fostering collaboration and innovation among Member States.
Project Impact
Maternal Mortality Rate
3,373
+
Neonatal Mortality Rate
194
+
Under 5 Mortality Rate
461.8
+